menu
    • menu

    Company profile for Nobelpharma America

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nobelpharma America, LLC is a U.S subsidiary of a purpose-driven Japanese pharmaceutical company which is seeking to enter the U.S. market to bring drugs and medical devices to individuals whose conditions are often overlooked because of the small number of patients affected. Our “patients first” approach is to develop drugs and medical devices that target medical conditions with limited or no other treatment options, rega...
    Nobelpharma America, LLC is a U.S subsidiary of a purpose-driven Japanese pharmaceutical company which is seeking to enter the U.S. market to bring drugs and medical devices to individuals whose conditions are often overlooked because of the small number of patients affected. Our “patients first” approach is to develop drugs and medical devices that target medical conditions with limited or no other treatment options, regardless of market size. We contribute to society by developing drugs and medical devices for diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nobelpharma AmericaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4520 East-West Highway, Suite 400, Bethesda, MD 20814
    Telephone
    Telephone
    301-244-5951
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nobelpharma-us.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Facial Angiofibroma Associated with TSC, is Focus of Disease Education Website
    Facial Angiofibroma Associated with TSC, is Focus of Disease Education Website

    17 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rare-disease-facial-angiofibroma-associated-with-tuberous-sclerosis-complex-tsc-is-focus-of-new-disease-education-website-launched-by-nobelpharma-america-301722641.html

    PR NEWSWIRE
    17 Jan 2023
    Share Share
    Nobelpharma USA Presents Results from Natural History Database of TSC Alliance
    Nobelpharma USA Presents Results from Natural History Database of TSC Alliance

    09 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nobelpharma-america-presents-findings-from-natural-history-database-of-the-tsc-alliance-on-the-characterization-of-facial-angiofibroma-and-the-use-of-topical-rapamycin-in-people-with-tuberous-sclerosis-complex-in-the-us-at-the-30t-301601652.html

    PRNEWSWIRE
    09 Aug 2022
    Share Share
    Nobelpharma America Debuts New Product, HYFTOR 0.2%
    Nobelpharma America Debuts New Product, HYFTOR 0.2%

    25 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nobelpharma-america-debuts-new-product-hyftor-sirolimus-topical-gel-0-2-at-the-2022-world-tsc-conference-301591913.html

    PRNEWSWIRE
    25 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search